Rocio Ir Macias

38PUBLICATIONS

105CO-AUTHORS

Predictive and prognostic markersHaematological tumoursCancer cell biologyCancer diagnosisMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (38)

Sort by Publication Date:

|May 27, 2026

Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell Models.

|May 04, 2026

Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinoma.

|Apr 28, 2026

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Dec 10, 2025

Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Aug 05, 2025

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné

|Jul 30, 2025

Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs.

Kevin Delgado-Calvo, Elisa Lozano, Oscar Briz

Pageof 7

Frequent Collaborators

20 joint publications

Jose Jg Marin

Oscar Briz

Jesper B Andersen

Guido Carpino

Alejandro Forner

Maria J Monte

Elisa Herraez

Jesus M Banales

Matias A Avila

Chiara Braconi

Frequent Collaborators

20 joint publications

Jose Jg Marin

7 joint publications

Oscar Briz

6 joint publications

Jesper B Andersen

6 joint publications

Guido Carpino